MARKET

BCTXZ

BCTXZ

Briacell Therapeutics Corp
NASDAQ
0.0799
-0.0095
-10.63%
Closed 15:45 05/15 EDT
OPEN
0.0800
PREV CLOSE
0.0894
HIGH
0.0846
LOW
0.0636
VOLUME
40.43K
TURNOVER
--
52 WEEK HIGH
1.180
52 WEEK LOW
0.0551
MARKET CAP
--
P/E (TTM)
-0.0025
1D
5D
1M
3M
1Y
5Y
1D
BriaCell adds ovarian cancer immunotherapy candidate Bria-OVA+ to pipeline
PUBT · 1d ago
BRIACELL EXPANDS PIPELINE TO INCLUDE AN OVARIAN CANCER IMMUNOTHERAPY CANDIDATE, BRIA-OVA+™
Reuters · 1d ago
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
Barchart · 2d ago
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
Barchart · 3d ago
BriaCell Phase 3 Bria-IMT breast cancer trial enrollment tops 230 patients
PUBT · 4d ago
BRIACELL THERAPEUTICS CORP - INTERIM TOPLINE DATA FROM PHASE 3 BRIA-ABC STUDY EXPECTED IN 2026
Reuters · 4d ago
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
Barchart · 5d ago
BriaCell adds NYU Langone Perlmutter as site for Phase 3 breast cancer trial
PUBT · 05/07 11:31
More

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTXZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTXZ stock methods without spending real money on the virtual paper trading platform.